Bivatuzumab BIWA 4: A New Therapeutic Candidate Bivatuzumab BIWA 4 shows a novel therapeutic agent for managing various malignancies. This immunoglobulin specifically targets a essential protein involved in tumor https://lucyrrwt303692.blog-gold.com/58782190/text